article thumbnail

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Drug Patent Watch

But what drives this complex system, and how do pharmaceutical companies ensure that their drug names meet the strict guidelines set by regulatory agencies? At the heart of pharmaceutical drug naming is the International Nonproprietary Name (INN) system. Share your thoughts in the comments below!

article thumbnail

Optimising cloud provisioning for pharmaceutical compliance and operational excellence

Express Pharma

Challenges in Pharmaceutical cloud infrastructure Playing within a stringent regulatory landscape, pharmaceutical companies often come across significant hurdles in managing their cloud infrastructure. Automating these processes can be critical in helping pharmaceutical companies manage their cloud infrastructure.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Responsible antibiotic use: How the industry can lead the way for evidence-backed guidelines

Express Pharma

This creates little financial incentive for pharmaceutical companies to invest in antibiotic research. The role of pharmaceutical companies Pharmaceutical companies are at the forefront of combating AMR. Self-medication and unnecessary prescriptions further exacerbate the problem.

article thumbnail

Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation

Express Pharma

Continued strategic focus on North America: US market accounts for anywhere between 30 per cent to 60 per cent of annual revenues for Leading Pharmaceutical companies in India. Companies will continue to acquire leadership capabilities with focus on these markets.

article thumbnail

The Global Generic Drug Market: Trends, Opportunities, and Challenges

Drug Patent Watch

To learn more about the global generic drug market, including its trends, opportunities, and challenges, check out our latest blog post: [link] What do you think is the most significant challenge facing the global generic drug market? Share your thoughts in the comments below.

article thumbnail

ACI To Host Multiple Events Featuring HP&M Speakers – Discounts Available to FDA Law Blog Readers

FDA Law Blog: Biosimilars

FDA Law Blog readers can use discount code S10-866-866L24.S His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations. More information about the conference can be found here.

article thumbnail

Union Budget 2025-26: A roadmap for India’s pharmaceutical leadership

Express Pharma

It is therefore essential that the government revisits the 200 per cent weighted tax benefit on R&D spending in order to encourage more pharmaceutical companies to invest in innovative research. However, massive R&D expenditure is necessary to drive the next generation of discoveries.